Newsroom

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration of Akoya Biosciences' spatial biology platform and Quanterix's decades of ultra-sensitive, quantitative immunoassay development from the SIMOA® technology, the Content Innovation Engine is organized around the hallmarks of cancer framework, giving researchers a sys...

BOSTON--(BUSINESS WIRE)--Solect Energy today announced the opening of its new headquarters at 87 Hayden Rowe Street in Hopkinton, Massachusetts, marking a key step in the company’s continued growth as a leading provider of commercial and public-sector solar and energy storage solutions. Designed to serve as Solect’s headquarters and to support its expanding team, the new facility provides a modern workspace built to bring teams together, host meetings with customers and partners, and enable reg...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

AUSTIN, Texas--(BUSINESS WIRE)--CareHive Health, a leader in personalized healthcare navigation and cost-savings solutions, today announced a new collaboration with Blue Cross and Blue Shield of Texas to provide a simple, guided experience to help Individual and Family Markets members identify more affordable, in-network options for care. While price transparency tools have increased access to healthcare pricing data, affordability remains a significant challenge, with U.S. healthcare spending...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Two Customer Posters to be Presented at the American Association of Cancer Research Annual Meeting...

BOSTON--(BUSINESS WIRE)--Acadian Asset Management Inc. (NYSE: AAMI) will announce its financial and operating results for the first quarter ended March 31, 2026, on Thursday, April 30, 2026. The Company will announce its results through a press release and related slide presentation at 7:30 a.m. Eastern Time and will hold a conference call and simultaneous webcast to discuss the results at 11:00 a.m. Eastern Time. To listen to the call or view the webcast, participants should: Dial-in       Loc...

OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the first quarter ended March 31, 2026 on April 29, 2026 after the close of the stock market. LSB’s management will host a conference call on Thursday, April 30, 2026 at 10:00 am ET / 9:00 am CT to discuss these results. Participating in the call will be Chairman & Chief Executive Officer, Mark Behrman, Executive Vice President & Chief Financial Office...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

BETHESDA, Md. & GAITHERSBURG, Md.--(BUSINESS WIRE)--Longhorn Vaccines and Diagnostics (LHNVD), an IND enabling-stage biopharmaceutical company, today announced it will present new preclinical data demonstrating that DRG5‑BD11, a novel human bispecific IgM monoclonal antibody, exhibits broad antibacterial activity against gram‑positive bacteria, gram‑negative bacteria, and mycobacteria, underscoring its potential as a new strategy to address antimicrobial resistance (AMR) and sepsis during a pos...